Serial #79020265
LIVE

Serial Number

79020265

Owner

NORTH CHINA PHARMACEUTICAL CO., LTD

Filing Date

Jun 28, 2005

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79020265 Trademark

Serial Number: 79020265 • Registration: 3223297

Serial #79020265 is a trademark filed by NORTH CHINA PHARMACEUTICAL CO., LTD on June 28, 2005. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NORTH CHINA PHARMACEUTICAL CO., LTD (2 trademarks)

No. 388 East Heping Road,

Entity Type: 99

NORTH CHINA PHARMACEUTICAL GROUP; CORPORATION

No. 388 Heping Donglu,
Shi Jiazhuang City , CN

Entity Type: 99

Trademark Details

Filing Date

June 28, 2005

Registration Date

March 27, 2007

Published for Opposition

January 9, 2007

Goods & Services

Western medicine and patent medicine, namely, antibiotics, synthetic antibacterial, antiviral, tuberculosis drugs, cardio-cerebrovascular system drugs, cancer drugs, gastrointestinal tract drugs, vitamins, urinary system drugs, coenzyme and biochemical drugs, immunity drugs, antipsychotic drugs, acetaminophen, for the treatment of acute bronchitis, infective endocarditis, cutaneous abscesses, necrotizing subcutaneous infections, lymphadenitis, gonorrhea, mycoplasmal pneumonia, pneumonia, lung abscess, pulmonary tuberculosis, pyogenic ostcomyclitis, septicemia, pyelonephritis, nephritis, urinary infection, phlegmon, peritonsillar abscess, purulent arthritis, pyogenic ostcomyclitis, purulent meningitis, scarlet fever, syphilis, typhoid, influenza, infantile diarrhea, gastric ulcer, gastritis, cardiac arrhythmias, angina pectoris, arteriosclerosis, hyperlipemia, hypertension, cerebral thrombosis, peripheral neuropathies, megaloblastic anemia, iron deficiency anemia, immunosuppressive agent, diabetes mellitus, hepatitis, carcinoma of stomach; biochemical medicine, namely, recombinant human granulocyte-macrophage colony stimulating factor for injection for the prevention and treatment of leukocytopenia caused by chemotherapy or radiotherapy in cancer patients, recombinant human granulocyte colony stimulating factor injection for prevention and treatment of leukopenia caused by chemotherapy or radiotherapy, and neutrupenia following transplantation of bone marrow, recombinant human erythropoetin injection used for anemia cause by renal insufficiency, including patients with chronic renal failure treated with or without hemodialysis, recombinant hepatitis B surface antigen vaccines to get rid of the contamination of viruses contained in human blood; tonics in the nature of medicine, for the treatment of acute bronchitis, infective endocarditis, cutaneous abscesses, necrotizing subcutaneous infections, lymphadenitis, gonorrhea, mycoplasmal pneumonia, pneumonia, lung abscess, pulmonary tuberculosis, pyogenic ostcomyclitis, septicemia, pyelonephritis, nephritis, urinary infection, phlegmon, peritonsillar abscess, purulent arthritis, pyogenic ostcomyclitis, purulent meningitis, scarlet fever, syphilis, typhoid, influenza, infantile diarrhea, gastric ulcer, gastritis, cardiac arrhythmias, angina pectoris, arteriosclerosis, hyperlipemia, hypertension, cerebral thrombosis, peripheral neuropathies, megaloblastic anemia, iron deficiency anemia, immunosuppressive agent, diabetes mellitus, hepatitis, carcinoma of stomach; dietetic substances adapted for medical use, for the treatment of acute bronchitis, infective endocarditis, cutaneous abscesses, necrotizing subcutaneous infections, lymphadenitis, gonorrhea, mycoplasmal pneumonia, pneumonia, lung abscess, pulmonary tuberculosis, pyogenic ostcomyclitis, septicemia, pyelonephritis, nephritis, urinary infection, phlegmon, peritonsillar abscess, purulent arthritis, pyogenic ostcomyclitis, purulent meningitis, scarlet fever, syphilis, typhoid, influenza, infantile diarrhea, gastric ulcer, gastritis, cardiac arrhythmias, angina pectoris, arteriosclerosis, hyperlipemia, hypertension, cerebral thrombosis, peripheral neuropathies, megaloblastic anemia, iron deficiency anemia, immunosuppressive agent, diabetes mellitus, hepatitis, carcinoma of stomach; dietetic foods adapted for medical purposes; diagnostic preparations for medical purposes preparations for acute bronchitis, infective endocarditis, cutaneous abscesses, necrotizing subcutaneous infections, lymphadenitis, gonorrhea, mycoplasmal pneumonia, pneumonia, lung abscess, pulmonary tuberculosis, pyogenic ostcomyclitis, septicemia, pyelonephritis, nephritis, urinary infection, phlegmon, peritonsillar abscess, purulent arthritis, pyogenic ostcomyclitis, purulent meningitis, scarlet fever, syphilis, typhoid, influenza, infantile diarrhea, gastric ulcer, gastritis, cardiac arrhythmias, angina pectoris, arteriosclerosis, hyperlipemia, hypertension, cerebral thrombosis, peripheral neuropathies, megaloblastic anemia, iron deficiency anemia, immunosuppressive agent, diabetes mellitus, hepatitis, carcinoma of stomach; fodder additives for medical purposes; nutritional additives for medical purposes; baby food; medical kits, comprising of antibiotics, synthetic antibacterial, antiviral, tuberculosis drugs, cardio-cerebrovascular system drugs, cancer drugs, gastrointestinal tract drugs, vitamins, urinary system drugs, coenzyme and biochemical drugs, immunity drugs, antipsychotic drugs, acetaminophen; all kinds of pills all included in this class, in the nature of antibiotics, synthetic antibacterial, antiviral, tuberculosis drugs, cardio-cerebrovascular system drugs, cancer drugs, gastrointestinal tract drugs, vitamins, urinary system drugs, coenzyme and biochemical drugs, immunity drugs, antipsychotic drugs, acetaminophen; insecticides; germicides; herbicides; agrochemical herbicides; gelatin for medical purposes; pectin containing preparations for pharmaceutical purposes, namely, antibiotics, synthetic antibacterial, antiviral, tuberculosis drugs, cardio-cerebrovascular system drugs, cancer drugs, gastrointestinal tract drugs, vitamins, urinary system drugs, coenzyme and biochemical drugs, immunity drugs, antipsychotic drugs, acetaminophen, for the treatment of acute bronchitis, infective endocarditis, cutaneous abscesses, necrotizing subcutaneous infections, lymphadenitis, gonorrhea, mycoplasmal pneumonia, pneumonia, lung abscess, pulmonary tuberculosis, pyogenic ostcomyclitis, septicemia, pyelonephritis, nephritis, urinary infection, phlegmon, peritonsillar abscess, purulent arthritis, pyogenic ostcomyclitis, purulent meningitis, scarlet fever, syphilis, typhoid, influenza, infantile diarrhea, gastric ulcer, gastritis, cardiac arrhythmias, angina pectoris, arteriosclerosis, hyperlipemia, hypertension, cerebral thrombosis, peripheral neuropathies, megaloblastic anemia, iron deficiency anemia, immunosuppressive agent, diabetes mellitus, hepatitis, carcinoma of stomach; veterinary medicine, namely, blood serum for veterinary purpose, vaccines for veterinary purpose, diagnosticum for veterinary purpose, chemical material medicine for veterinary purpose, chemical preparations for veterinary purpose, antibiotics for veterinary purpose, biomedicine for veterinary purpose, radioactivity drug for veterinary purpose; medicine, namely, antibiotics, synthetic antibacterial, antiviral, tuberculosis drugs, cardio-cerebrovascular system drugs, cancer drugs, gastrointestinal tract drugs, vitamins, urinary system drugs, coenzyme and biochemical drugs, immunity drugs, antipsychotic drugs, acetaminophen, for the treatment of acute bronchitis, infective endocarditis, cutaneous abscesses, necrotizing subcutaneous infections, lymphadenitis, gonorrhea, mycoplasmal pneumonia, pneumonia, lung abscess, pulmonary tuberculosis, pyogenic ostcomyclitis, septicemia, pyelonephritis, nephritis, urinary infection, phlegmon, peritonsillar abscess, purulent arthritis, pyogenic ostcomyclitis, purulent meningitis, scarlet fever, syphilis, typhoid, influenza, infantile diarrhea, gastric ulcer, gastritis, cardiac arrhythmias, angina pectoris, arteriosclerosis, hyperlipemia, hypertension, cerebral thrombosis, peripheral neuropathies, megaloblastic anemia, iron deficiency anemia, immunosuppressive agent, diabetes mellitus, hepatitis, carcinoma of stomach; Chinese medicine material, namely, antibiotics, synthetic antibacterial, antiviral, tuberculosis drugs, cardio-cerebrovascular system drugs, cancer drugs, gastrointestinal tract drugs, vitamins, urinary system drugs, coenzyme and biochemical drugs, immunity drugs, antipsychotic drugs, acetaminophen; medical plasters; sanitary sterilizing preparations; isopropyl alcohol for medical use; glucose tablets used as a dietary supplement; starch for pharmaceutical purposes, namely, antibiotics, synthetic antibacterial, antiviral, tuberculosis drugs, cardio-cerebrovascular system drugs, cancer drugs, gastrointestinal tract drugs, vitamins, urinary system drugs, coenzyme and biochemical drugs, immunity drugs, antipsychotic drugs, acetaminophen, for the treatment of acute bronchitis, infective endocarditis, cutaneous abscesses, necrotizing subcutaneous infections, lymphadenitis, gonorrhea, mycoplasmal pneumonia, pneumonia, lung abscess, pulmonary tuberculosis, pyogenic ostcomyclitis, septicemia, pyelonephritis, nephritis, urinary infection, phlegmon, peritonsillar abscess, purulent arthritis, pyogenic ostcomyclitis, purulent meningitis, scarlet fever, syphilis, typhoid, influenza, infantile diarrhea, gastric ulcer, gastritis, cardiac arrhythmias, angina pectoris, arteriosclerosis, hyperlipemia, hypertension, cerebral thrombosis, peripheral neuropathies, megaloblastic anemia, iron deficiency anemia, immunosuppressive agent, diabetes mellitus, hepatitis, carcinoma of stomach; primary medicine of western medicine, namely, antibiotics, synthetic antibacterial, antiviral, tuberculosis drugs, cardio-cerebrovascular system drugs, cancer drugs, gastrointestinal tract drugs, vitamins, urinary system drugs, coenzyme and biochemical drugs, immunity drugs, antipsychotic drugs, acetaminophen, for the treatment of acute bronchitis, infective endocarditis, cutaneous abscesses, necrotizing subcutaneous infections, lymphadenitis, gonorrhea, mycoplasmal pneumonia, pneumonia, lung abscess, pulmonary tuberculosis, pyogenic ostcomyclitis, septicemia, pyelonephritis, nephritis, urinary infection, phlegmon, peritonsillar abscess, purulent arthritis, pyogenic ostcomyclitis, purulent meningitis, scarlet fever, syphilis, typhoid, influenza, infantile diarrhea, gastric ulcer, gastritis, cardiac arrhythmias, angina pectoris, arteriosclerosis, hyperlipemia, hypertension, cerebral thrombosis, peripheral neuropathies, megaloblastic anemia, iron deficiency anemia, immunosuppressive agent, diabetes mellitus, hepatitis, carcinoma of stomach

Filing History

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Mar 27, 2026 REM4
INTERNATIONAL REGISTRATION RENEWED
May 15, 2025 RNWL
CHANGE OF OWNER RECEIVED FROM IB
Jun 11, 2021 CHLD
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Mar 18, 2017 NA71
REGISTERED-SEC.71 ACCEPTED
Mar 18, 2017 71AG
TEAS SECTION 71 RECEIVED
Mar 17, 2017 ES71
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 17, 2017 TCCA
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Mar 27, 2016 REM4
INTERNATIONAL REGISTRATION RENEWED
Jul 16, 2015 RNWL
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Apr 3, 2013 NA71
REGISTERED-SEC.71 ACCEPTED
Apr 3, 2013 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 3, 2013 APRE
TEAS SECTION 71 RECEIVED
Mar 19, 2013 ES71
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 19, 2013 TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 19, 2013 TCCA
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 6, 2008 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 25, 2007 FICS
FINAL DISPOSITION PROCESSED
Sep 25, 2007 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 19, 2007 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 27, 2007 R.PR
PUBLISHED FOR OPPOSITION
Jan 9, 2007 PUBO
NOTICE OF PUBLICATION
Dec 20, 2006 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 20, 2006 PREV
ASSIGNED TO LIE
Nov 9, 2006 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 7, 2006 CNSA
AMENDMENT FROM APPLICANT ENTERED
Sep 25, 2006 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 15, 2006 CRFA
PAPER RECEIVED
Sep 15, 2006 MAIL
REFUSAL PROCESSED BY IB
Apr 7, 2006 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 15, 2006 RFCS
REFUSAL PROCESSED BY MPU
Mar 15, 2006 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 10, 2006 RFCR
NON-FINAL ACTION WRITTEN
Mar 9, 2006 CNRT
ASSIGNED TO EXAMINER
Mar 6, 2006 DOCK
NEW APPLICATION ENTERED
Mar 6, 2006 NWAP
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 2, 2006 REPR